US biotech firm Moderna said Tuesday it would enter the final stage of human testing for its COVID-19 vaccine on July 27, after promising results were published in an influential magazine. The Phase 3 trial will recruit 30,000 participants in the US, half to receive the vaccine at dose levels …
Read More »